VTAK
Catheter Precision, Inc.
Key Financials
Operating Income
$-21143000
↓ 88.1%
Revenue
$819000
↑ 95.0%
Net Income
$-17183000
↓ 3.2%
Gross Profit
$756000
↑ 100.0%
EPS (Diluted)
$-25.98
↑ 89.5%
Shareholders' Equity
$7.1M
↓ 40.0%
Cash & Equivalents
$88000.00
↓ 96.9%
Total Liabilities
$9.2M
↓ 42.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/18/2026 | View on SEC |
| 10-Q | 5/18/2026 | View on SEC |
| NT 10-Q | 5/18/2026 | View on SEC |
| SCHEDULE 13G/A | 5/14/2026 | View on SEC |
| 10-K/A | 4/30/2026 | View on SEC |
| 8-K | 4/23/2026 | View on SEC |
| 8-K | 4/15/2026 | View on SEC |
| 8-K | 3/31/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 4 | 3/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VTAK |
| Company Name | Catheter Precision, Inc. |
| CIK | 1716621 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 973-691-2000 |